Insider · CIK 0001335892
Chris LaVictoire Mahai
Files at HQH (abrdn Healthcare Investors), HQL (abrdn Life Sciences Investors), THQ (abrdn Healthcare Opportunities Fund), THW (abrdn World Healthcare Fund). First filing Jul 20, 2026, latest Jul 20, 2026.
In brief
Chris LaVictoire Mahai files SEC Form 4 as director at HQH (abrdn Healthcare Investors), and also at HQL (abrdn Life Sciences Investors), THQ (abrdn Healthcare Opportunities Fund), THW (abrdn World Healthcare Fund). Since Jul 20, 2026, Chris LaVictoire Mahai has reported 4 open-market buys worth $42k and 0 open-market sells worth $0, the latest filed on Jul 20, 2026.
A track record needs three past buys with six months of prices behind them; Chris LaVictoire Mahai has 0, so none is measured yet.
The newest scored trade: bought $11k of THQ on Jul 16, 2026, filed Jul 20, 2026, scored 23 (weak). In the last 12 months: 4 buys worth $42k and 0 sells worth $0.
Where the trades landed
Last year at the 3 companies this insider has traded most, with each buy and sell on the bar it happened.
THQ: abrdn Healthcare Opportunities Fund
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
THW: abrdn World Healthcare Fund
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
HQH: abrdn Healthcare Investors
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | THQbuy abrdn Healthcare Opportunities Fund | $11k 568 shares | - | - | |
| 23Weak | THWbuy abrdn World Healthcare Fund | $11k 796 shares | - | - | |
| 23Weak | HQHbuy abrdn Healthcare Investors | $11k 501 shares | - | +52% from low-6% from high | |
| 23Weak | HQLbuy abrdn Life Sciences Investors | $10k 527 shares | - | +72% from low-5% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | THQ abrdn Healthcare Opportunities Fund | POpen-market purchase Common Stock | +568 | $18.49 | $11k | 568 | Jul 20, 2026 |
| Jul 16, 2026 | THW abrdn World Healthcare Fund | POpen-market purchase Common Stock | +796 | $13.20 | $11k | 796 | Jul 20, 2026 |
| Jul 16, 2026 | HQH abrdn Healthcare Investors | POpen-market purchase Common Stock | +501 | $20.96 | $11k | 501 | Jul 20, 2026 |
| Jul 16, 2026 | HQL abrdn Life Sciences Investors | POpen-market purchase Common Stock | +527 | $19.92 | $10k | 527 | Jul 20, 2026 |
Questions about Chris LaVictoire Mahai
Answered from the filings on this page, as of the latest one.
Is Chris LaVictoire Mahai buying or selling?
In the last 12 months Chris LaVictoire Mahai reported 4 open-market buys worth $42k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $11k of THQ on Jul 16, 2026. Grants, option exercises and tax withholding are not counted.
How did Chris LaVictoire Mahai's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Chris LaVictoire Mahai has 0.
Where does Chris LaVictoire Mahai file Form 4?
Chris LaVictoire Mahai has filed Form 4 at HQH (abrdn Healthcare Investors); HQL (abrdn Life Sciences Investors); THQ (abrdn Healthcare Opportunities Fund); THW (abrdn World Healthcare Fund). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.